Tech Company Financing Transactions
InBrain Pharma Funding Round
On 5/12/2025, InBrain Pharma landed $2 million in funding from private investors.
Transaction Overview
Company Name
Announced On
5/12/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support its PERCEPAR project (PERfusion CErébrale de dopamine, a therapeutic innovation for PARkinson's patients).
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
70 Rue Du Docteur Yersin, Bio Incubateur Parc Eurasante
Loos, 59120
France
Loos, 59120
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
InBrain Pharma is a biotech specialized in brain infusion of drugs for neurological disorder management. InBrain Pharma's approach is unique and groundbreaking in the treatment of advanced Parkinson's disease, offering continuous dopaminergic stimulation in the brain of patients at the stage of severe and refractory motor complications related with L-dopa oral treatment. This pharmacological modulation of dopamine neurotransmission is achieved by continuous, titrated intracerebroventricular (i.c.v.) administration of dopamine. This new therapeutic modality opens the era of precision medicine for neurodegenerative diseases management.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Véronique Foutel
Chief Scientific Officer
Matthieu Fisichella
Co-Founder
David Devos
Co-Founder
Caroline Moreau
Browse more venture capital transactions:
Prev: 5/12/2025: X-Bow Systems venture capital transaction
Next: 5/12/2025: ALT DRX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs